Nearly two-thirds of industry experts ranked IQVIA as the leader among decentralized trial solutions – more than any other technology or service provider.1 Our tested DCT model leverages technology and specialized services to engage participants within the community, and facilitate patient centric care including pre-screening, telemedicine visits, at-home treatment, or mobile research nurses and staff services.
Built on a foundation of global clinical operations capabilities and privacy compliance expertise, IQVIA Decentralized Trials is the first service provider to receive GDPR compliance validation from TRUSTArc, marking the first instance of a DCT service receiving this European data privacy validation.2
1Industry Standard Research, 2021
and over 30 indications using IQVIA Decentralized Trials
IQVIA Decentralized Trials Platform helps sponsors deploy adaptable, patient-centric DCT technology for trials of all sizes, customized to fit any study and any indication – anywhere on the globe.
Available in dozens of languages, our end-to-end DCT platform expands traditional site boundaries to deliver a more efficient, more personalized experience without compromising the precision and rigor of the trial.
IQVIA’s DCT platform empowers patients across the globe with a concierge digital experience, including: text reminders, alerts, live chat, 24/7 support, and a scheduling tool to confirm or reschedule study visits.